Trials / Completed
CompletedNCT06312501
Remote Patient Monitoring for Patients With Heart Failure in France
Evaluating the Effectiveness of Remote Patient Monitoring (Satelia® Cardio) for Patients With Heart Failure (TELESAT-HF Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (actual)
- Sponsor
- Satelia · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this multicenter observational longitudinal cohort study is to evaluate the ability of a Remote Patient Monitoring (RPM) program to prevent cardiac decompensation by detecting weak signals of decompensation early in patients with chronic heart failure in France. The main question it aims to answer is whether an RPM solution can provide the improvement in overall patient survival Participants will answer to questionnaires provided by the RPM solution for the follow-up of their condition. Researchers will compare the following cohorts to see if RPM can improve their condition: * Cohort 1: using RPM for follow-ups. * Cohort 2: conventional care and not using any devices and solutions for the follow-ups.
Detailed description
TELESAT study is a national-scale observational prospective cohort study conducted in France from August 2018 to December 2022. The study was conducted using the French national health data system known as the Système National des Données de Santé (SNDS) which covers approximately 99% of the French population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Satelia®Cardio | Use of a remote patient monitoring system by NP Medical. |
| OTHER | Conventional care | No use of RPM solutions for follow-up |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2021-12-31
- Completion
- 2022-12-31
- First posted
- 2024-03-15
- Last updated
- 2025-04-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06312501. Inclusion in this directory is not an endorsement.